Monday, June 4

8:00-9:00am Morning Coffee & Pre-Conference Short Course & Symposia Registration

9:00 Chairperson’s Remarks

Andreas Jeromin, Ph.D., Director, Business Development and Analytical Service Lab, Banyan Biomarkers, Inc.

9:05 Biomarkers for Neurotoxicity: Trends and Technologies

Andreas Jeromin, Ph.D., Director, Business Development and Analytical Service Lab, Banyan Biomarkers, Inc.

9:35 Current Biomarkers of Neurotoxicity: Conventional Morphological Analyses

Brad Bolon, DVM, Ph.D., DACVP, DABT, Veterinary Pathologist, Department of Veterinary Biosciences and Associate Professor, Clinical, The Ohio State University

10:05 GFAP and Related Glial Proteins as Biomarkers of Neurotoxicity

James O’Callaghan, Ph.D., Head, Molecular Neurotoxicology Laboratory, Health Effects Laboratory Division, Centers for Disease Control and Prevention-NIOSH

10:30am Coffee Break

10:45 Translational Studies of TSPO as a Biomarker of Neurotoxicity

Tomas Guilarte, Ph.D., Leon Hess Professor & Chairman, Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University

11:15 Speaker to be Announced

11:45 PANEL DISCUSSION

12:15pm LUNCH ON OWN

2:00 Functional Assessment of Neurotoxicity: Cognitive Dysfunction in Animal Models and Its Relevance to Humans

Merle G. Paule, Ph.D., Fellow, A.T.S. , Director, Division of Neurotoxicology , National Center for Toxicological Research, Food and Drug Administration

2:30 Preclinical In Vivo Imaging of Neurotoxicity

Serguei Liachenko, Ph.D., Director of Bio-Imaging, National Center for Toxicological Research, Food and Drug Administration

3:00 Using Preclinical fMRI to “Finger Print” Drugs With Black Box Warnings for Suicide

Craig Ferris, Ph.D., Professor, Department of Pharmaceutical Sciences, and Director, Center for Translational Imaging, Northeastern University

3:30 Refreshment Break

4:00 Speaker to be Announced

4:30 PANEL DISCUSSION

5:15 End of Symposium